Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.
Journal: Transplantation and cellular therapy
Published: April 03, 2026
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Reversible cerebral vasoconstriction syndrome following ciltacabtagene autoleucel therapy for relapsed multiple myeloma: a case report.
Journal: Frontiers in immunology
Published: January 07, 2026
Genomic Determinants and Clinical Outcomes of Second Primary Hematological Malignancies in Patients with B-cell Cancers.
Journal: Transplantation and cellular therapy
Published: October 28, 2025
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 09, 2025
Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 01, 2025
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.
Journal: Haematologica
Published: February 07, 2025
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.
Journal: Journal of hematology & oncology
Published: December 24, 2024
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 20, 2024
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 11, 2023
Last Updated: 09/26/2026